Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection by Belew, A. Trey et al.
RESEARCH ARTICLE
Comparative transcriptome profiling of
virulent and non-virulent Trypanosoma cruzi
underlines the role of surface proteins during
infection
A. Trey Belew1☯, Caroline Junqueira2☯, Gabriela F. Rodrigues-Luiz3☯, Bruna M. Valente4,
Antonio Edson R. Oliveira4, Rafael B. Polidoro5, Luciana W. Zuccherato4, Daniella
C. Bartholomeu3, Sergio Schenkman5, Ricardo T. Gazzinelli2,4, Barbara A. Burleigh6, Najib
M. El-Sayed1*, Santuza M. R. Teixeira4*
1 Department of Cell Biology and Molecular Genetics and Center for Bioinformatics and Computational
Biology, University of Maryland, College Park, Maryland, United States of America, 2 Centro de Pesquisas
Rene Rachou, Fundac¸ão Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil, 3 Departamento de
Parasitologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil, 4 Departamento
de Bioquı´mica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil,
5 Departmento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo,
São Paulo, Brazil, 6 Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of
Public Health, Boston, Massachusetts, United States of America
☯ These authors contributed equally to this work.
* santuzat@ufmg.br (SMRT); elsayed@umd.edu (NES)
Abstract
Trypanosoma cruzi, the protozoan that causes Chagas disease, has a complex life cycle
involving several morphologically and biochemically distinct stages that establish intricate
interactions with various insect and mammalian hosts. It has also a heterogeneous popula-
tion structure comprising strains with distinct properties such as virulence, sensitivity to
drugs, antigenic profile and tissue tropism. We present a comparative transcriptome analy-
sis of two cloned T. cruzi strains that display contrasting virulence phenotypes in animal
models of infection: CL Brener is a virulent clone and CL-14 is a clone that is neither infective
nor pathogenic in in vivo models of infection. Gene expression analysis of trypomastigotes
and intracellular amastigotes harvested at 60 and 96 hours post-infection (hpi) of human
fibroblasts revealed large differences that reflect the parasite’s adaptation to distinct envi-
ronments during the infection of mammalian cells, including changes in energy sources, oxi-
dative stress responses, cell cycle control and cell surface components. While extensive
transcriptome remodeling was observed when trypomastigotes of both strains were com-
pared to 60 hpi amastigotes, differences in gene expression were much less pronounced
when 96 hpi amastigotes and trypomastigotes of CL Brener were compared. In contrast, the
differentiation of the avirulent CL-14 from 96 hpi amastigotes to extracellular trypomasti-
gotes was associated with considerable changes in gene expression, particularly in gene
families encoding surface proteins such as trans-sialidases, mucins and the mucin associ-
ated surface proteins (MASPs). Thus, our comparative transcriptome analysis indicates that
the avirulent phenotype of CL-14 may be due, at least in part, to a reduced or delayed
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expression of genes encoding surface proteins that are associated with the transition of
amastigotes to trypomastigotes, an essential step in the establishment of the infection in the
mammalian host. Confirming the role of members of the trans-sialidase family of surface
proteins for parasite differentiation, transfected CL-14 constitutively expressing a trans-siali-
dase gene displayed faster kinetics of trypomastigote release in the supernatant of infected
cells compared to wild type CL-14.
Author summary
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is an infection that
occurs in several Latin American countries, resulting in a mild illness or in severe damage
of the heart and intestinal tract. Such a broad spectrum of clinical manifestations observed
in Chagas disease patients is likely due to differences in host susceptibility as well as to a
large heterogeneity among T. cruzi isolates. The identification of virulence factors that are
differentially expressed in the parasite population is a valuable strategy for understanding
of the distinct interactions that occur between this pathogen and its host, which may or
may not lead to pathogenesis. By comparing the gene expression profiles of two T. cruzi
strains that display contrasting virulence phenotypes in animal models of infection, we
identified a central role for genes encoding surface proteins that is associated with the dif-
ferentiation from intracellular replicative amastigotes to infective trypomastigotes. We
showed that the expression of these genes occurs differentially within the two strains and
this difference may be a factor that impacts parasite survival and dissemination in the
mammalian host.
Introduction
Trypanosoma cruzi is the etiological agent of Chagas disease, a disease affecting at least 8 mil-
lion people throughout Latin America and for which there are only two drugs available, both
with poor efficacy and harmful side effects (http://www.who.int/mediacentre/factsheets/fs340/
en/). T. cruzi infection begins with metacyclic trypomastigotes released in the feces of a triato-
minae vector during a blood meal. After reaching the bloodstream through skin cuts or
through the mucosa, trypomastigotes invade different cell types in the mammalian host. Once
in the cytoplasm, they differentiate into replicative non-flagellated amastigotes, which undergo
several rounds of division before differentiating again into trypomastigotes and bursting out of
the host cell. Bloodstream trypomastigotes, ingested by the vector during a blood meal, differ-
entiate into epimastigotes and replicate in the insect midgut [1]. Such a complex life cycle,
involving several morphologically and biochemically distinct parasite forms and very different
host environments, requires complex regulatory mechanisms to direct gene expression and
the adaptive strategies that allow parasites to thrive within distinct hosts.
The sequence of the T. cruzi CL Brener genome, with an estimated haploid size of 55 Mb,
revealed a highly repetitive genome with protein coding genes organized in long, unidirec-
tional polycistronic transcription units [2]. Because of its hybrid nature and repetitive content,
which prevented its complete assembly, the CL Brener genome is represented by two datasets
of contigs, each corresponding to one haplotype [2,3]. The two haplotypes are referred to as
“esmeraldo-like” or “non-esmeraldo-like” based on their parental strains [2,4]. Several genes,
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particularly members of large multicopy gene families, were excluded from the current assem-
bly of the CL Brener genome, which is predicted to contain 41 pairs of chromosomes [3].
The naturally occurring T. cruzi population is comprised of a highly heterogeneous pool of
strains with striking intra-species variation and exhibiting wide-ranging biological characteris-
tics in experimental settings such as distinct morphology, growth rate, curves of parasitemia,
virulence, sensitivity to drugs, antigenic profile, metacyclogenesis and tissue tropism. This var-
iability may explain the wide-ranging pathogenesis observed in T. cruzi infections (reviewed
by Buscaglia and DiNoia [5]). Those studies recently converged on a classification that pro-
poses the existence of six major groups in T. cruzi, also known as discrete typing units (DTUs):
I to VI [6]. Although clonal evolution is predominant, evidence indicates that genetic exchange
between parasites has occurred. CL Brener, the cloned reference strain used for the T. cruzi
genome project, is among the strains that are the products of hybridization events. More
recently, genome sequences from several other T. cruzi strains have been reported [7,8], allow-
ing comparative analyses that are essential for the understanding of the variable courses of
infection and clinical forms of Chagas disease. Most importantly, the study of T. cruzi genetic
diversity provides essential information for the identification of new drug targets and antigenic
candidates for better diagnostic tools and vaccine development.
In addition to investigating genomic variation, differences in gene expression also provide
valuable information necessary to fully understanding the complex patterns of interaction
between different T. cruzi strains and their hosts. Being part of a group of early branching
eukaryotes, T. cruzi possesses unique mechanisms to control the expression of its repertoire
of about 12,000 genes. Similar to other trypanosomatid genomes, the T. cruzi genome is consti-
tutively transcribed into long polycistronic transcripts containing sequences from several
functionally unrelated genes. Mature, monocistronic mRNAs for protein-coding genes are
produced after the pre-mRNA is processed through trans-splicing and polyadenylation, two
coupled reactions determined by polypyrimidine-rich tracts located within intergenic regions
(see Arau´jo and Teixeira, 2011 for a review [9]). As a consequence of polycistronic transcrip-
tion and the scarcity of typical RNA polymerase II promoters, T. cruzi gene expression is regu-
lated at the post-transcriptional level. Various studies have characterized regulatory sequences
present in the 3’ untranslated regions (UTRs) of different genes, which act as protein-binding
sites and, together with RNA binding proteins, are key elements in the control of individual
mRNA steady levels during the parasite life cycle [9].
Genome-wide expression studies showing global changes in gene expression during the T.
cruzi life cycle not only help to unravel the processes involved in the parasite’s interaction with
different hosts but also provide an invaluable tool for the understanding of molecular mecha-
nisms controlling gene expression in a group of early branching eukaryotes. Steady-state tran-
scriptome analyses, based on microarray hybridizations of cDNAs derived from epimastigotes,
metacyclic trypomastigote, tissue culture derived trypomastigotes and axenically-induced
amastigotes of the Brazil strain show that almost 5000 genes exhibit statistically significant up
or down regulation in at least one of the four life cycle stages [10]. More recently, RNA-seq
analysis of the Y strain during infection of primary human foreskin fibroblasts revealed that
~15 to 30% of the predicted protein-coding genes undergo significant changes in gene expres-
sion when epimastigotes, trypomastigotes and amastigotes were compared. Focusing on the
parasite energy metabolism, this study highlighted the importance of mitochondrial electron
transport for intracellular survival of T. cruzi amastigotes [11]. Similar RNA-seq analysis of try-
pomastigotes, amastigotes and epimastigotes of the Dm28c strain showed an increased expres-
sion of genes encoding surface proteins in extracellular trypomastigotes [12]. In a comparative
transcriptome analysis of T. cruzi strains belonging to the two main genetic groups present in
the T. cruzi population, the Sylvio (DTU I) and Y (DTU II) strains, Houston-Ludlam et al.
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(2016) showed the existence of striking similarities among the differentially expressed core
genes [13]. However, genome-wide analyses comparing T. cruzi strains with clear differences
in their virulence properties have yet to been conducted.
Here, we present a comparative transcriptomic analysis, across multiple life cycle stages for
two nearly isogenic T. cruzi cloned strains, CL Brener and CL-14, which were originally cloned
from the parental CL strain [14]. In contrast to CL Brener, CL-14 is non-infectious and non-
pathogenic in vivo, even when inoculated into newborn [15,16] or immune deficient, CD8-/-
mice [17] that are otherwise highly susceptible to T. cruzi infection. Importantly, after inocula-
tion in adult animals, CL-14 prevents the development of parasitemia and mortality following
challenge with the virulent CL strain [16,18,19]. Since vaccination with live CL-14 induces a
potent and long-lasting parasite-specific humoral and T-cell mediated immunity against chal-
lenge with highly virulent strains of T. cruzi, the immunological adjuvant properties of the
CL-14 clone is being explored as a possible vaccine vector for induction of T-cell mediated
immunity against other diseases [17]. Preliminary comparisons of the CL Brener and CL-14
genomes, based on shotgun sequences, revealed only few differences in the core gene content
of both strains. Although a direct comparative study between the two fully assembled genomes
is still under way, our initial analyses showed that the CL-14 genome, which is also a hybrid,
TcVI genome, is 99.73% identical to CL Brener (S. Teixeira, in preparation). Thus, in the
absence of major differences identified so far at the genome level, we analyzed the CL-14 and
CL Brener transcriptomes and compared them with the aim of identifying changes in gene
expression that could explain the differences in virulence between the two strains.
Results and discussion
Distinct outcomes of the in vitro infection with CL Brener and CL-14
cloned strains
The availability of two genetically similar T. cruzi strains that display marked differences in vir-
ulence presents a unique opportunity to identify fundamental phenotypic differences associ-
ated with the colonization and completion of the intracellular infection cycle in mammalian
host cells (Fig 1A). To characterize the dynamics of intracellular infection by T. cruzi CL
Brener and CL-14 cloned strains, parallel infections of low passage human fibroblasts (HFF)
were established and monitored for several days post-infection. The capacities of CL Brener
and CL-14 trypomastigotes to infect HFF were comparable with a similar fraction of the host
cell monolayer colonized by these parasites (Fig 1B). In contrast, analysis of the number of
intracellular amastigotes over time revealed significant differences in amastigote growth rates,
with CL-14 lagging behind the faster growing CL Brener (Fig 1C). The slower growth of CL-14
amastigotes correlated with delayed release of trypomastigotes from infected cells upon com-
pletion of the intracellular growth and differentiation cycle (Fig 1D). As a consequence, signifi-
cantly fewer trypomastigotes were released into the supernatant of CL-14-infected cells as
compared to monolayers infected with CL Brener (Fig 1D). These findings suggest that the
intracellular stages of CL-14 exhibit both growth and developmental defects, which may
underlie the inability of CL-14 parasites to establish patent infection in vivo.
Global transcriptome assessment from developmental stages in both
strains
To further characterize the differences in host cell infection phenotype, a comparative tran-
scriptome analysis was performed focused on the mammalian-infective stages of CL Brener
and CL-14. Total RNA was isolated from extracellular trypomastigotes and from fibroblasts
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infected with each strain in parallel, at time points post-infection that capture active amastigote
replication (60 hr) and the transition from amastigotes to trypomastigotes (96 hr) (Fig 1A).
The mRNA populations derived from biological triplicates of each sample were sequenced on
the Illumina platform and the total number of reads generated from all libraries as well as the
percentages of reads mapped to the T. cruzi CL Brener reference genome are shown in S1
Table. Consistent with the general trend observed in the numbers of intracellular amastigotes
per cell, the proportion of parasite reads mapping to the reference genome at 96 hours post-
infection (hpi) was smaller in cells infected with CL-14 (12.1% on average) than with CL
Brener (37.0% on average). As shown in Fig 1C, the numbers of amastigotes per cell at day 5
post infection were higher in CL Brener infected cells than in CL-14 infected cells. Also consis-
tent with data shown in Fig 1C, a smaller difference (6.7% versus 10.7%, respectively) was
observed at 60 hpi, when the numbers of intracellular amastigotes were similar between the
two infections.
Mapped sequencing data derived from all libraries were analyzed using a variety of meth-
ods, including principal component analysis (PCA) and hierarchical clustering, to inspect the
Fig 1. Comparative course of infection of human fibroblasts with T. cruzi CL Brener and CL-14. Intracellular T.
cruzi life stages in mammalian cells: extracellular T. cruzi trypomastigotes actively penetrate mammalian cells where
they differentiate into amastigotes and escape the vacuole before beginning to proliferate at ~24 hours post-infection
(A). Amastigotes replicate intracellularly in the host cell cytoplasm for 3–5 days, and then differentiate into motile
trypomastigotes that are eventually released upon disruption of the host cell. Tissue-culture derived trypomastigotes of
the CLB and CL-14 T. cruzi strains were similarly able to establish intracellular infection in cultured HFF (B) but exhibited
markedly different intracellular growth dynamics as amastigotes. (C) Differences in the peak day of trypomastigote
release from infected monolayers (D).
https://doi.org/10.1371/journal.ppat.1006767.g001
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relationships between samples and to identify potential outliers. The resulting PCA plot and
heat maps (S1 Fig), after normalization, showed the expected clustering between biological
triplicates with the exception of one sample generated from RNA isolated from CL Brener try-
pomastigotes (CLB.Tryp.1), which was identified as an outlier and excluded from subsequent
analyses. Following normalization and surrogate variable analysis, the hierarchical clustering
of the remaining samples revealed an intriguing set of observations (Fig 2A). The global tran-
scriptome profiles of the CL-14 amastigotes at 96 hpi, while resembling their CL Brener coun-
terparts, clustered tightly with the profiles of CL Brener amastigotes at 60 hpi. Additionally,
the profiles from CL-14 trypomastigotes displayed a greater similarity to mammalian intracel-
lular amastigote stages (from both strains) than the CL Brener trypomastigotes. The PCA plot
displayed similar characteristics (Fig 2B). These findings suggested that a delayed expression
of a large number of genes might be occurring in CL-14 amastigotes.
Temporal patterns of surface proteins expression may play a role in
parasite virulence
The numbers of T. cruzi genes that emerged as differentially expressed (DE) with adjusted P
value of<0.05, in pairwise comparisons of similar developmental stages of CL Brener and CL-
14, are shown in Fig 3 (see S2, S3 and S4 Tables for the complete datasets). For both parasite
strains, comparisons between an intracellular stage (A60 or A96) and the extracellular trypo-
mastigote stage (Tryp) yielded a larger set of differentially expressed (DE) genes than similar
contrasts between the intracellular stages (A60 vs A96) (Fig 3). This finding, which agrees with
our recent characterization of global transcriptome changes in different stages of the T. cruzi Y
strain parasites [11], was anticipated considering the extensive morphological and biochemical
differences that exist between the intracellular and extracellular parasite life stages.
Fig 2. Global statistical assessment of biological replicates. Heat-map (A) and Principal Component Analysis
(PCA) plots (B) of RNA-Seq data generated from the libraries mapped to the T. cruzi genome following removal of
rRNA/tRNA features. Once the outlier sample was removed and data passed through normalization and surrogate
variable analysis, the strong clustering by condition became evident in both analyses. In both plots, each sample is
color coded by developmental stage/strain (Tryp: trypomastigotes; A60: amastigotes collected 60 hpi; A96:
amastigotes collected 96 hpi).
https://doi.org/10.1371/journal.ppat.1006767.g002
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As demonstrated (Fig 1B–1D), the CL Brener strain completes its intracellular life cycle in
mammalian host cells more rapidly and more efficiently than CL-14: similar differences are
predicted to be reflected in the global gene expression patterns. Changes in the CL Brener
global transcriptome appeared to be more pronounced with twice the number of significantly
up- and down-regulated genes when compared to CL-14 (Fig 3), particularly when amastigotes
at 60 hpi and 96 hpi were compared. The most significant differences appeared to lie in the
temporal patterns of expression of some multi-gene family encoding surface proteins, which
constituted 26% to 89% of highly DE genes (>2 fold). This is best illustrated when members of
multigene families of surface proteins such as trans-sialidase (TS), mucin, mucin-associated
surface proteins (MASP) and GP63 were color-coded on MA plots for all three DE contrasts
(trypomastigote vs. 60 hpi amastigotes, 60 hpi vs. 96 hpi and 96 hpi amastigotes vs. trypomasti-
gotes) (Fig 4). In the contrast representing the transition of extracellular trypomastigotes to
amastigotes at 60 hpi (Tryp to A60), an expected down-regulation of genes encoding TS,
MASP and mucin was conspicuous for both strains and there were few differences in the
behavior of most gene families in CL-14 when compared to CL Brener. The latter observation
was supported by a two-sample Kolmogorov-Smirnov (K-S) test, which quantifies and tests
the distance between two distributions and a Welch’s test of the mean log fold changes (logFC)
among the genes in each family (S5 Table). The resulting K-S distance values were small for
MASP, mucin, RHS and GP63 and TS (D = 0.05, 0.05, 0.7, 0.09, respectively) and so were the
differences in the mean logFC values. A clear and diverging pattern emerged when the selected
multi-gene families were compared during differentiation from 60 to 96 hpi amastigotes.
Genes encoding MASP, mucin and TS were up-regulated en masse as CL Brener began its
transformation back to trypomastigotes while showing little change in CL-14 (D = 0.39, 0.35
and 0.27, respectively). A careful examination of the mean logFC change values (S5 Table)
Fig 3. Differential gene expression across T. cruzi CL-14 and CL Brener developmental stages. Bar plots of the
numbers of genes deemed significantly differentially expressed (adjusted P value <0.05) in (A) CL-14 and (B) CL Brener.
The numbers of genes in each category are defined as: log2 fold changes |0–1| (light cyan for positive, light plum for
negative), |1–2| (light sky blue for positive, orchid for negative), and |2+| (dodger blue and purple respectively). The
diverging patterns of expression are shown by changing bar patterns.
https://doi.org/10.1371/journal.ppat.1006767.g003
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reveals a more vigorous up-regulation of MASP and mucin genes when compared to TS genes,
which may reflect the roles played by these cell surface proteins during parasite development
in the mammalian host. The most striking observation was a delayed up-regulation of CL-14
genes encoding MASP, mucin and TS, marking a slow transition of amastigotes to trypomasti-
gotes when compared to CL Brener and suggesting that the processes that regulate the expres-
sion of this specific group of genes encoding parasite surface proteins may be a major factor
underlying the avirulent phenotype of CL-14. It is also possible that a smaller proportion of
CL-14 amastigotes differentiates into trypomastigotes, resulting in the release of fewer trypo-
mastigotes in the extracellular milieu. Members of the DGF family displayed a similar pattern
of expression in CL Brener and CL-14, however their down-regulation was considerably more
pronounced as CL-14 amastigotes transform into trypomastigotes (S5 Table). It is also impor-
tant to note that the clear temporal asynchronicity in expression patterns of MASP, mucin and
TS genes in CL-14 when contrasted to CL Brener were not observed for members of other
multigene families such as GP63 and RHS.
Fig 4. Comparative global transcriptional expression patterns of T. cruzi genes encoding polymorphic cell surface proteins in CL Brener
and CL-14. MA plots depicting the log2 fold change (logFC) of genes against the average expression level during the transition of CL Brener and CL-
14 across developmental stages. Each dot represents one gene and colored dots represent members of the four of the six largest T. cruzi gene
families analyzed: MASP (red), Mucin (blue), Trans-sialidase (purple), and GP63 (green). Dots above and below the red lines represent differentially
expressed genes (logFC >1).
https://doi.org/10.1371/journal.ppat.1006767.g004
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Gene ontology enrichment analyses
A gene ontology (GO) enrichment analysis of DE genes in CL-14 and CL Brener revealed
some trends similar to those observed in the transciptome analysis of T. cruzi Y strain [11].
Because the differentiation from trypomastigotes into intracellular amastigotes is accompanied
by a massive down regulation of the expression of gene families encoding trans-sialidase,
MASP and mucin surface proteins, we masked all DE genes that belong to any of the six largest
multigenic families (MASP, mucin, DGF-1, Trans-sialidase, RHS and GP63) present in the CL
Brener genome before performing the GO enrichment analysis. The transformation from
extracellular trypomastigotes to intracellular replicative amastigotes was accompanied by
enrichment of several biological processes including translation (GO:0006412), protein folding
(GO:0006457), chromosome organization (GO:0051276), ion transport (GO:0006811), lipid
biosynthesis (GO:0008610), and oxidoreductase activity (GO:0016491) in both parasite strains
(Table 1). As discussed by Li et al. [11], these changes reflect the rapid proteome and mem-
brane lipid remodeling as well as metabolic adaptations to distinct carbon sources that are
required for parasite replication and intracellular survival. Interestingly, GO enrichment anal-
yses described in the Y strain revealed that genes related to ion transport are among the most
highly differentially expressed genes in amastigotes at 48 and 72 hpi compared to trypomasti-
gotes. One of those genes (TcCLB.509197.39) belongs to the ZIP family of metal transporters
that was also found highly expressed in 60 hpi amastigotes of CL Brener and CL-14 compared
to trypomastigotes (logFC of 4.9 and 4.3, respectively). It is important to note that while both
strains shared most of the same enriched GO processes, the numbers of genes that were signifi-
cantly up regulated (with logFC>1) within the GO categories were consistently higher in CL
Brener amastigotes than in CL-14. For example, whereas 109 genes related to oxidoreductase
activity were up-regulated during the transformation of CL Brener trypomastigotes into 60 hpi
amastigotes, only 58 genes were up-regulated in 60 hpi amastigotes of CL-14. Likewise, the
numbers of genes involved in ion transport and lipid biosynthesis that were up-regulated in 60
hpi amastigotes were in general 50% lower in CL-14 when compared to CL Brener. These data
indicate that the differentiation of non-dividing trypomastigotes into replicative and more
metabolic active amastigotes may be occurring at a slower pace in CL-14 compared to CL
Brener. On the other hand, when amastigotes at 60 hpi and 96 hpi are compared, the number
of genes in the two GO categories that are upregulated in 96 hpi amastigotes of CL-14 are
greater than in CL Brener, which also indicates a slower reprogramming of gene expression
during intracellular differentiation of CL-14 compared to CL Brener. Among the two GO cate-
gories that were enriched with down-regulated genes when trypomastigotes from either strain
differentiated into amastigotes, was a hexose transport biological process. In the current T.
cruzi genome database only one gene encoding a glucose transporter (TcCLB.506355.10) is
annotated, but after a more careful inpection, we identified two additional hexose transporter
orthologues. Transcript levels of all three hexoxe transporters were significantly down-regu-
lated in amastigotes from both strains (for TcCLB.506355.10, with a logFC -2.418 in CL Brener
and -2.747 in CL-14), as expected, since carbohydrates do not constitute a significant energy
source for intracellular amastigotes [20].
When we contrasted the GO enrichment analyses for the amastigotes’ transition from 60
hpi to 96 hpi in both strains, a few notable differences were observed, including a category
involved with cilium or flagellum-dependent cell motility (GO:0001539), which appeared
up-regulated only in CL Brener at 96 hpi. Ciliary and flagellar motility also emerged as an
enriched GO terms associated with mature T. cruzi amastigotes as early as at 48 hpi in Y strain
[11]. Another interesting difference from CL Brener included an enrichment of CL-14 genes
involved in chromosome organization (GO:0051276) and ion transport (GO:0006811) that
Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi
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Table 1. Gene ontology (GO) categories (biological process, BP and metabolic function, MF) enriched across the T. cruzi CL Brener and CL-14 life
cycles.
GO Term (CL Brener) P value Num. DE Total Num.
Trypomastigote to Amastigote 60 hpi, up-regulated
GO:0006412 translation (BP) 2.52E-55 177 475
GO:0016491 oxidoreductase activity (MF) 6.13E-17 109 455
GO:0006811 ion transport (BP) 3.57E-16 56 165
GO:0006457 protein folding (BP) 1.87E-15 45 118
GO:0051276 chromosome organization (BP) 2.47E-12 30 70
GO:0008610 lipid biosynthetic process (BP) 5.87E-10 40 134
Trypomastigote to Amastigote 60 hpi, down-regulated
GO:0004672 protein kinase activity (MF) 2.78E-04 32 418
GO:0008645 hexose transport (BP) 4.02E-02 1 1
Amastigote 60 hpi to Amastigote 96 hpi, up-regulated
GO:0006565 L-serine catabolic process (BP) 3.51E-05 3 3
GO:0001539 cilium or flagellum-dependent cell motility (BP) 7.82E-03 3 12
Amastigote 60 hpi to Amastigote 96 hpi, down-regulated
GO:0006457 protein folding (BP) 1.01E-05 8 118
GO:0006730 one-carbon metabolic process (BP) 2.30E-04 2 3
GO:0006811 ion transport (BP) 1.56E-02 5 165
GO:0016491 oxidoreductase activity (MF) 2.00E-02 9 455
Amastigote 96 hpi to Trypomastigote, up-regulated
GO:0004672 protein kinase activity (MF) 2.13E-04 18 418
GO:0008645 hexose transport (BP) 1.67E-02 1 1
Amastigote 96 hpi to Trypomastigote, down-regulated
GO:0016491 oxidoreductase activity (MF) 1.80E-15 69 455
GO:0006457 protein folding (BP) 1.97E-12 29 118
GO:0006757 ATP generation from ADP (BP) 1.41E-10 14 31
GO:0008610 lipid biosynthetic process (BP) 3.25E-10 28 134
GO:0006811 ion transport (BP) 2.71E-09 30 165
GO:0051276 chromosome organization (BP) 1.56E-08 18 70
GO:0009116 nucleoside metabolic process (BP) 9.22E-05 18 124
GO:0006412 translation (BP) 1.49E-03 41 475
GO Term (CL-14) P value Num. DE Total Num.
Trypomastigote to Amastigote 60 hpi, up-regulated
GO:0006412 translation (BP) 1.39E-73 166 475
GO:0051276 chromosome organization (BP) 3.56E-13 26 70
GO:0006811 ion transport (BP) 5.08E-07 31 165
GO:0006457 protein folding (BP) 5.11E-07 25 118
GO:0016491 oxidoreductase activity (MF) 9.90E-06 58 455
GO:0008610 lipid biosynthetic process (BP) 2.99E-03 19 134
Trypomastigote to Amastigote 60 hpi, down-regulated
GO:0004672 protein kinase activity (MF) 7.48E-04 29 418
GO:0008645 hexose transport (BP) 3.68E-02 1 1
Amastigote 60hpi to Amastigote 96 hpi, up-regulated
GO:0051276 chromosome organization (BP) 2.79E-04 10 70
GO:0006811 ion transport (BP) 7.65E-03 14 165
Amastigote 60hpi to Amastigote 96 hpi, down-regulated
GO:0016491 oxidoreductase activity (MF) 1.40E-02 24 455
(Continued )
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was sustained in CL-14 amastigotes at 96 hpi. We noted earlier that genes encoding several cell
surface proteins were up-regulated en masse as CL Brener began its transformation back to try-
pomastigotes, i.e., when 60 hpi and 96 hpi amastigotes were compared. In CL-14, the induced
expression of these surface gene families became evident only when 96 hpi amastigotes and
trypomastigotes were compared. The GO enrichment analyses indicated that in addition to
genes encoding cell surface proteins, amastigotes of CL-14 at 96 hpi did not express genes
required for the last steps of amastigote-to-trypomastigote differentiation, such as genes
involved with flagellum-dependent motility (TcCLB.510955.40, TcCLB.509005.10,
TcCLB.508793.14). Also, genes related to protein folding (GO:0006457) and ion transport
(GO:0006811), which were down-regulated in 96 hpi amastigotes compared to 60 hpi amasti-
gotes in CL Brener did not show significant differences in gene expression when 60 hpi and 96
hpi amastigotes of CL-14 were compared.
When GO enrichment was examined for the differential expression from amastigotes at 96
hpi to trypomastigotes, an expected enrichment of protein kinase activity (GO:0004672) and
hexose transport (GO:0008645) was identified amongst the upregulated genes in both strains.
These finding are in agreement with data that showed that glucose is the main energy source
for the parasite in the bloodstream and also with increased protein modification, such as phos-
phorylation of MASPs, that is required for the abundant expression of cell surface glycoproteins
in trypomastigotes [12,20,21,22]. Also consistent with a decreased metabolism and macromo-
lecular biosynthesis of the non-replicative trypomastigotes, down-regulated genes in both
strains were enriched in protein translation (GO:0006412), protein folding (GO:0006457),
ion transport (GO:0006811), oxidoreductase activity (GO:0016491), lipid biosynthesis
(GO:0008610) and chromosome organization (GO:0051276). Hence, in addition to confirming
the associations between gene expression and the metabolic differences that are known to
occur during the intracellular differentiation, our GO enrichment analyses revealed further dif-
ferences in gene expression between CL Brener and CL-14 during the transition from early to
late stages of the intracellular amastigote development. It can be assumed that, in addition to a
distinct program controlling the expression of multigene families encoding cell surface glyco-
proteins, other differences in gene expression related to changes in the parasite metabolism
Table 1. (Continued)
GO Term (CL Brener) P value Num. DE Total Num.
Amastigote 96 hpi to Trypomastigote, up-regulated
GO:0004672 protein kinase activity (MF) 1.40E-02 30 418
GO:0008645 hexose transport (BP) 4.86E-02 1 1
Amastigote 96 hpi to Trypomastigote, down-regulated
GO:0006412 translation 1.73E-47 151 475
GO:0051276 chromosome organization 8.50E-15 31 70
GO:0006811 ion transport 1.05E-11 46 165
GO:0006720 isoprenoid metabolic process 3.47E-06 11 23
GO:0016491 oxidoreductase activity 2.60E-05 71 455
GO:0006457 protein folding 1.62E-04 24 118
GO:0008610 lipid biosynthetic process 1.81E-04 27 134
GO:0006730 one-carbon metabolic process 1.00E-03 3 3
GO:0009116 nucleoside metabolic process 1.30E-03 23 124
(P-value cutoff of <0.05; Number of DE genes and total number of genes in each GO term are shown)
https://doi.org/10.1371/journal.ppat.1006767.t001
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and cellular structures may also contribute to the distinct behavior of the two strains during
infection of mammalian cells.
Differential expression of RNA-binding proteins
To further investigate the regulatory mechanisms controlling the distinct transcriptional pro-
grams that drive the development from intracellular amastigotes to the extracellular trypomas-
tigote stage in the two cloned strains, we analyzed the expression of RNA-binding proteins
(RBPs) that are differentially expressed throughout the infection of the host cell by CL Brener
and CL-14. Using homology searches to four protein domains known to be present in RNA
binding proteins (PUF (Pumilio), zinc finger, RNA recognition motif (RRM) and Alba
domains), we identified a total of 253 T. cruzi sequences representing 147 genes (since two
alleles were identified for most genes), which are shown in S6 Table. This list includes all genes
encoding T. cruzi RBPs containing the RRM motif identified by Gaudenzi et al. (2005) [23]
and Guerra-Slompo et al. (2012) [24], Pumilio-type RNA binding proteins identified by Caro
et al. (2006) [25] and Zinc Finger containing proteins identified by Kramer et al. (2010) [26],
with an additional 13 genes. Among all the putative RBP-encoding genes identified, six genes
were differentially expressed in CL Brener (logFC>2, P value< 0.05) during differentiation
between 60 hpi and 96 hpi amastigotes and from amastigotes to trypomastigotes (Fig 5A–5F).
Amongst them is the gene encoding a CCCH zinc finger (ZFN) motif-containing protein
(TcCLB.511511.6) that was significantly upregulated in trypomastigotes from CL Brener as
well as in CL-14 (Fig 5A). Previous studies with the Dm28c strain of T. cruzi indicate that this
RBP acts as a regulatory factor possibly involved with metacyclogenesis [27], whereas the T.
brucei homologue TbZFN1 (Tb927.6.3490) was identified as a factor that is upregulated during
differentiation from bloodstream to procyclic forms [28].
Five transcripts encoding RBPs are upregulated in amastigotes from both strains, indicating
that they may control expression of genes involved with replication and intracellular survival
of the parasite in the mammalian host cell. TcCLB.511727.190 encodes a RRM containing pro-
tein, which was significantly upregulated in 60 hpi and 96 hpi amastigotes compared to trypo-
mastigotes of CL Brener and CL-14 (Fig 5B). Its T. brucei homologue DRBD18 (Double RNA
Binding Domain, encoded by Tb927.11.14090) can be modified by arginine methylation [29].
TcCLB.469785.40, identified as amastigote-specific not only in CL Brener and CL-14 but
also in the Y strain [11], is also a member of the DRBD family whose T. brucei ortholog
(Tb927.6.3480) has been identified as the post-transcriptional repressor DRBD5 [30] (Fig 5C).
Similar to TcCLB.469785.40, transcript levels of the RBP encoded by TcCLB.509551.60 is
increased in 60 hpi amastigotes of CL Brener compared to 96 hpi amastigotes and trypomasti-
gotes as well as in amastigotes of the Y strain up to 12 hpi [11] (Fig 5D).
TcCLB.504005.6, annotated as RBP5 (Fig 5E) encodes an RBP that is upregulated in 96 hpi
amastigotes of CL Brener and CL-14, as well as in the Y strain amastigotes at 72 hpi amasti-
gotes but not at 48 hpi [11]. Similarly, transcript levels of the T. cruzi PUF9 (TcCLB.506563.10)
are also up-regulated in CL Brener 96 hpi amastigotes as well as in Y strain amastigotes at 72
hpi compared to amastigotes at early stages of the infection (Fig 5F). In T. brucei, PUF9
(Tb927.1.2600) stabilizes a group of transcripts during S-phase and may be involved with the
temporal coordination of nuclear and kinetoplast replication [31]. It is therefore tempting to
speculate that the RBPs encoded by TcCLB.504005.6 and TcCLB.506563.10 act as regulatory
factors involved with the final steps of amastigote-trypomastigote differentiation and the
release of trypomastigotes from infected cells.
Because of their critical role in regulating gene expression in trypanosomatids, we searched
for RBPs whose expression significantly differs in the CL Brener and CL-14 transcriptomes. In
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Fig 5. Expression patterns of selected genes encoding RNA binding proteins. Expression values for
genes encoding RPBs were extracted from S4 Table. The selected genes were observed to be up-regulated
in CL Brener and CL-14 trypomastigotes (A), in CL Brener and CL-14 amastigotes (B-F), and only in
trypomastigotes from CL-14 (G). Only genes encoding proteins with RNA binding domains whose transcripts
present logFC > 2 comparing amastigotes at 60 hpi and 96 hpi and trypomastigote stages are shown. When
sequences from both haplotypes are present, the sequences shown in the graphs correspond to Esmeraldo-
like alleles, but similar expression patterns were obtained with the non-Esmeraldo alleles.
https://doi.org/10.1371/journal.ppat.1006767.g005
Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006767 December 14, 2017 13 / 23
contrast to all six differentially expressed RBP genes shown in Fig 5A–5F, TcCLB.507611.300
is constitutively expressed in the mammalian stages of CL Brener as well as in the Y strain [11],
but its transcript levels are significantly increased in trypomastigotes of CL-14 (Fig 5G).
TcCLB.507611.300 encodes a spliceosomal protein that is part of the U1A small nuclear ribo-
nucleoprotein complex as indicated by the studies with the T. brucei ortholog (Tb927.10.830)
[32]. In addition to further investigating whether the differences observed in the expression
of CL Brener and CL-14 RBP genes, such as TcCLB.469785.40 and TcCLB.509551.60, which
may be involved with the control of steady state levels of their target transcripts, further studies
are also needed to verify whether the differential expression of an RBP involved in mRNA pro-
cessing may cause any impact on the expression of genes related to the virulence of CL-14
trypomastigotes.
Constitutive expression of a trans-sialidase gene in CL-14 affects
amastigote to trypomastigote differentiation
Because data shown in Fig 4 and S5 Table indicated that several genes encoding surface protein
families are been expressed at later time points during intracellular infection of CL-14 com-
pared to CL Brener, we sought to test whether altering the expression of a member of these
multigene families might affect parasite differentiation inside the host cell. We selected the
trans-sialidase (TS) gene Tc00.1047053509495.30 (whereby named TS95.30) because it belongs
to TcS group I and encodes an enzymatically active TS that contains the C-terminal SAPA
(Shed Acute Phase Antigen) repeats known to be expressed only in the mammalian stages of
the parasite life cycle [33]. Our RNA-seq analyses confirmed the expression of TS95.30 in
amastigotes and trypomastigotes of CL Brener and CL-14 but also highlighted distinct expres-
sion levels of TS95.30, which is highly upregulated (FC = 9.8) in 96 hpi amastigotes compared
to 60 hpi in CL Brener, and less so in CL-14 (FC = 3.5).
The complete open reading frame of TS95.30 was cloned in the pROCKNeo vector [34]
and transfected into CL-14 epimastigotes using the linearized form of the vector shown in Fig
6A. As described previously, transfection with linearized pROCKNeo vector results in the inte-
gration of the DNA construct in the tubulin locus and, because signals for mRNA processing
of the foreign gene are derived from the constitutively expressed housekeeping genes TcP2β
(at the 5’ end) and gapdh (at the 3’ end), the pROCKNeoTS transgene can be constitutively
expressed in all parasite life cycle stages, including epimastigotes [34]. After selecting a neomy-
cin-resistant population as well as transfected cloned cell lines, total RNA and protein extracts
from these cultures were subjected to northern (Fig 6B) and western blot analyses (Fig 6C).
For northern blot, we used a probe derived from the 3’ region of the TS95.30 gene and for the
western blot we used an anti-SAPA antibody that detects the expression of members belonging
to TS group 1 sub-family. As shown in Fig 6B, two cloned epimastigote cell lines derived from
G418-resistant, CL-14 parasites transfected with the TS gene (clones TS 14 and TS 22) showed
increased levels of TS mRNA compared to untransfected CL-14 or with epimastigotes from
CL Brener. These two transfected cell lines plus two additional ones (TS 16 and TS 18), all of
them showing increased TS protein expression compared to WT CL-14 (Fig 6C), were selected
and tested in in vitro infection assays. No differences in the growth curves of epimastigote cul-
tures from all four transfected cell lines compared to WT CL-14 and CL Brener epimastigotes
were observed (S2 Fig).
The infection capacity of the transfected parasites was tested in vitro by incubating Vero
cells with equal numbers of tissue culture derived trypomastigotes from WT CL Brener, CL-14
and from the CL-14 transfected cell lines (TS 14 and TS 22) constitutively expressing TS95.30.
As shown in Fig 6D and 6E, parasites from all four cell lines transfected with TS displayed
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faster kinetics of trypomastigote release in the supernatant compared to untransfected CL-14
or with CL-14 parasites transfected with the empty vector. Although no significant differences
in the numbers of intracellular amastigotes were observed, the numbers of trypomastigote
released by cells infected with transfected CL-14 parasites was increased compared to cells
infected with WT CL-14 or with CL-14 transfected with the empty vector. This result indicates
that the constitutive expression of one member of the TS gene family is sufficient to alter the
differentiation from amastigote to trypomastigotes, a process that occurs intracellularly before
trypomastigotes are released to infect new host cells. Although constitutive TS expression facil-
itates intracellular amastigote to trypomastigote differentiation and parasite egress from
infected cells, constitutive expression of TS is not sufficient to restore parasite virulence. When
the two cloned, transfected CL-14 cell lines TS 14 and TS 22 were inoculated into BALB/c
mice, similar to WT CL-14 infected animals, no parasites were detected in the bloodstream at
any time point after infection (S3 Fig). It should be noted that, cells infected with one trans-
fected cell line, TS 22, showed a total number of trypomastigotes released in the supernatant
that was statistically equivalent to the number of released trypomastigotes in CL Brener
infected cells (Fig 6D). It is therefore assumed that differences regarding the gene expression
profiles of trypomastigotes from both strains also contribute to determine the distinct viru-
lence phenotypes observed during infection in vivo. The mechanisms by which the increased
expression in CL-14 of a TS gene affects amastigote to trypomastigote differentiation need
to be investigated. The work of Rubin-de-Celis and colleagues, [35] suggests that sialic acid
present on lysosomal membrane glycpoproteins are targets of TS, since over-expression of TS
in the Y strain facilitates escape of amastigotes from the parasitophorous vacuole. It is also
possible that the constitutive expression of TS triggers other changes in gene expression or
Fig 6. Constitutive expression of a TS gene in CL-14. The pROCKNeo vector used for transfection of CL-14 has the TS gene
(Tc00.1047053509495.30) flanked by the ribosomal promoter and sequences containing signals for mRNA processing derived from the
constitutively expressed housekeeping genes TcP2β (at the 5’ end) and gapdh (at the 3’ end) (A). Total RNA purified from epimastigotes from WT
and transgenic parasites were subjected to northern blot and hybridized with a 32P-labelled probe that contains sequences corresponding to the C-
terminal SAPA repeats present in the TS gene. Lower panel shows ethidium bromide staining of rRNAs in the same gel before transferring to the
membrane (B). Total protein extracts from epimastigotes from WT and transgenic parasites were evaluated for the expression of the transfected
TS gene by western blotting with a monoclonal antibody anti-SAPA (C). The infection profiles of four cloned cell lines derived from CL-14 parasites
transfected with the TS gene or with the empty pROCKNeo vector, were compared to WT CL-14 and CL Brener in in vitro infection assays of Vero
cells. Equal numbers of tissue culture derived trypomastigotes from each parasite cultures were added to Vero cell monolayers and the total
number of trypomastigotes released in the supernatant (D) or the numbers of trypomastigotes released in the supernatant each day post-infection
were evaluated over 8 days (E). Five replicates for each infection experiment were performed.
https://doi.org/10.1371/journal.ppat.1006767.g006
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modifications at the cell surface that affect parasite differentiation. It has been shown that gly-
cosylphosphatidylinositol anchored proteins such as TS, mucins and MASPs are transported
to the parasite surface through the contractile vacuole complex, in a trafficking process that
involves the small GTPase protein Rab11 [36]. Therefore, the possibility that early overexpres-
sion of TS in CL-14 may cause changes in membrane trafficking in a way that affects mem-
brane remodeling events required for amastigote to trypomastigote differentiation, should
also be considered. These hypotheses are currently being investigated using RNA-seq analyses.
As predicted by the differential expression and GO analyses, adequate expression of mucins,
MASPs and/or several other genes may also be needed during late stages of intracellular devel-
opment of the parasite, along the expression of TS genes, to restore CL-14 virulence in animal
models of infection. Our results also suggest that a genome wide DNA manipulation strategy
allowing the inspection of multiple factors will be necessary to fully address the question
regarding differences in the virulence phenotype among the two T. cruzi strains.
Concluding remarks
Our in vivo infection assays confirmed previous studies, which have shown that, in contrast to
an infection with the CL Brener clone, no patent parasitemia can be detected in immune com-
petent animals that were inoculated with trypomastigotes from the attenuated CL-14 clone.
However, in vitro infection assays showed that CL-14 trypomastigotes are able to infect and
multiply within different cell types (this study tested infection of HFF and Vero cells), although
the CL-14 infection resulted in lower numbers of intracellular amastigotes during early time
points and a markedly reduced number of trypomastigotes released by the CL-14 infected cells
compared to the CL Brener infection. One might conclude that a deficient capacity of CL-14
amastigotes to differentiate into trypomastigotes is a key factor accounting for the CL-14 atten-
uated phenotype. The results from the in vitro infection assays prompted us to investigate the
molecular basis of the attenuated phenotype of CL-14 by performing gene expression analyses
at two time points of the intracellular development of the two strains. As shown previously
[11], once reaching the cell cytoplasm, CL Brener amastigotes replicate for about 4 days, before
they differentiate back into trypomastigotes and rupture the cell. Our comparative transcrip-
tome analyses showed that the transition of extracellular trypomastigotes to amastigotes at 60
hpi was accompanied by only few differences in gene expression between the two parasite
strains, including a similar down-regulation of multi-gene families encoding TS, MASP and
mucin. In contrast, large differences in the transcriptome remodeling were observed between
the two strains when gene expression at 60 hpi and 96 hpi were compared, particularly regard-
ing the expression of gene families encoding surface proteins, which are up-regulated with
faster kinetics in CL Brener than in CL-14. Thus, the RNA-seq data presented in this study
point to a central role of this group of proteins in the process of differentiation from the repli-
cative amastigote to infective trypomastigotes and establishment of infection in the mamma-
lian host.
Our RNA-seq analysis is also consistent with experimental data that shows no differences
in the parasite’s invasion capacity or ability to multiply in the cytoplasm of the mammalian
cell. As observed during in vivo infection, it is possible that CL-14 amastigotes are able to mul-
tiply in a limited number of tissues of the infected animal at least during the initial stages of
the infection, but the delayed expression of genes encoding surface proteins prevents the
release of trypomastigotes in the bloodstream and in neighboring tissues. This is consistent
with several reports showing that, although infection with CL-14 does not result in patent
parasitemia, it results in efficient immunity against a lethal challenge with virulent parasites
[18,19], or against a human tumor antigen if this antigen is expressed by the parasite [17].
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Because CL-14 retains its capacity to multiply during the first round of infection after trypo-
mastigote inoculation, this initial multiplication within host tissues may be sufficient to induce
a highly efficient immune response that includes a balanced Th1/Th2 cytokine production
that is beneficial for the host [19].
In one study addressing the basis of the non-virulent phenotype, Atayde and co-workers
[37] showed that metacyclic forms of the CL strain and from the CL-14 clone express compa-
rable levels of gp82, a member of the TS family, and gp35/50, a member of the mucin family of
glycoproteins. Although we did not analyze the gene expression profile of metacyclic forms,
the RNA-seq data obtained for trypomastigotes from CL Brener and CL-14 indicated that
once the parasites differentiated into trypomastigotes, their gene expression profiles still
showed large differences, particularly regarding genes belonging to the multi-gene families of
surface proteins. In another study where the number of extracellular trypomastigotes was
determined after infection of CHO-K1 cells with CL-14, Tonelli and co-workers [38] found
that increased numbers of trypomastigotes are released in the supernatants if cells are kept at
33˚C instead of 37˚C. In addition, the numbers of trypomastigotes released into the medium
were 2.5 to 3-fold higher if the cultures were supplemented with 20 or 200 microM proline.
We confirmed the increased capacity of CL-14 to differentiate from amastigote to trypomasti-
gote if the temperature is lowered from 37 to 33˚C (S4 Fig). The thermo-sensitive character of
the differentiation process of CL-14 will be investigated using RNA-seq data collected at both
temperatures. Using RNA-seq analyses, we are also planning to investigate whether the consti-
tutive expression of one member of the trans-sialidase in CL-14 affects the expression of other
genes that may also be involved with the amastigote to trypomastigote differentiation. Finally,
RNA immunoprecipitation analyses using tagged versions of the three RNA binding proteins
(TcCLB.507611.300, TcCLB.506563.10 and TcCLB.469785.40), identified as being differen-
tially expressed in both strains, are also underway with the aim of identifying their target
genes, which may correspond to genes directly involved with the T. cruzi differentiation pro-
gram. However, the lack of a fully assembled genome poses a major limitation that needs to be
resolved before we can perform a conclusive comparative analysis between these strains.
Efforts towards the generation of the complete sequences of all chromosomes from CL Brener
and CL-14 are underway using the long read sequencing technology by PacBio. With this new
sequencing strategy we should be able to resolve all the complex regions in this parasite
genome, particularly regions where large multigene families are present. Together with addi-
tional gene expression analyses, further genome studies investigating gene copy number varia-
tion will help understand the diversity of the T. cruzi population and its impact on parasite
infection.
Materials and methods
Parasite cultures, RNA extraction and cDNA sequencing
The two cloned strains of Trypanosoma cruzi, CL Brener and CL-14 were provided by Egler
Chiari, from the Federal University of Minas Gerais. Mammalian-infective stages of T. cruzi
were maintained by weekly passage in monkey kidney cell line LLc-MK2 (ATCC CCL-7)
grown at 37˚C and 5% CO2 [11]. Trypomastigotes collected from infected monolayers were
centrifuged for 10 min at 1,700g and then allowed to swim up from the pellet for 4 hrs before
collecting the pure highly motile fraction in the supernatant and washing in Dulbecco’s Modi-
fied Eagle Medium (DMEM) supplemented with 2% fetal bovine serum (DMEM-2). For
RNA-Seq studies, experimental infections were established in human foreskin fibroblasts
(HFF; ATCC CRL-2522) by exposing sub-confluent monolayers to purified trypomastigotes
(80 parasites: host cell) for 2 hours at 37˚C, 5% CO2 followed by rinsing in PBS 3–5 times to
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remove remaining extracellular parasites to achieve infection of 60–70% of host cells. Total
RNA was extracted from infected HFF at 60 and 96 hours post-infection and from tissue cul-
ture derived trypomastigotes released in the supernatants of infected HFFs using the Trizol
reagent (Invitrogen, CA, USA). After DNAse treatment, the RNA was further purified using
the Qiagen RNeasy mini kit, poly(A)+ RNA was selected using oligo-dT following Illumina
TruSeqv2 instructions and its integrity was assessed using an Agilent 2100 bioanalyzer. cDNA
libraries were constructed using a TruSeq RNA Sample Prep Kit Version II (Illumina) with an
average insert size of ~300 nt. Libraries were sequenced on an Illumina HiSeq 1500.
Data quality assessment and visualization
Quality assessment of 100 nucleotide paired-end reads was performed via an initial evaluation
with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and biopieces
(http://biopieces.org). Illumina sequencing adapters and low quality sequences were removed
with Trimmomatic [39]. The remaining sequences were mapped separately against the Esmer-
aldo haplotype of T. cruzi CL Brener genome, non-Esmeraldo haplotype, and a combination
of both haplotypes along with the unassigned contigs using the TriTrypDB version 9.0 genome
and annotation data (http://tritrypdb.org/common/downloads/release-9.0/). Alignments were
done using TopHat2 [40] version 2.0.14 and options allowing a single randomly placed map-
ping per read (-g 1) and without a novel splice junction search (-G gff_file). Mapping was per-
formed with the same options for the samples collected from human cell samples using the
ensembl GRCh37.62.v3 release. Alignments were compressed, sorted, and indexed using sam-
tools [41] in order to include only proper pairs and counted against the set of annotated tran-
scripts using HTSeq [42]. The resulting count tables were passed to R for outlier testing,
sample clustering, visualization, and differential expression analyses with the hpgltools pack-
age (http://github.com/elsayed-lab/hpgltools/). A table with raw counts for all samples and
conditions is available as supplementary data (S7 Table).
Differential expression and gene ontology analyses
Samples were tested for significant outliers using a mix of hierarchical clustering and principal
component analysis. Non-expressed and weakly expressed genes, defined as having <2 reads
per million in n of the samples, where n is the size of the smallest group of replicates (here
n = 2), were removed prior to differential expression (DE) analysis. Of the 24,887 genes
analyzed, 23,191 remained after applying the low-count filter. Multiple data normalization
methods were tested, including a mix of: trimmed median of M-values, quantile, log transfor-
mation, and counts per million. Surrogate variables / batches were queried with a mix of
methods from sva [43] and ruv [44]. Differential expression analyses were performed and
compared using surrogate estimates from svaseq with limma [45], DESeq2 [46], EdgeR [47],
and a statistically uninformed basic method as a diagnostic control. Genes were considered
‘significant’ when the limma observed |log2 fold-change| was greater than 1.0 (logFC>1) and
the adjusted P value was less than 0.05. The set of significant genes for each contrast of interest
was passed to Goseq [48] for the parasite samples and g:Profiler [49] for the human samples
through its R interface.
Parasite transfection and characterization
Transfected CL-14 epimastigotes were obtained by cloning the complete open reading frame
(ORF) of the TS gene Tc00.1047053509495.30 into the XbaI-XhoI sites of pROCKNeo plasmid
[34]. T. cruzi epimastigotes were transfected, selected with 200 microg/mL of G418 and several
G418 resistant cloned cell lines were generated as previously described [17,34]. Expression of
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TS95.30 was detected by northern blot using a 32P labelled PCR fragment corresponding to the
C-terminal domain of the transfected gene and by western blot using an anti-TS-SAPA mono-
clonal antibody (kindly provided by Sergio Shenkman, Federal University of São Paulo)
according to previously described protocols [17]. In vivo infection of BALB/c mice (purchased
from Biote´rio Central, Federal University of Minas Gerais) were carried out as previously
described [17]. In vitro infection of Vero cells (ATCC CCL-81) with tissue culture derived try-
pomastigotes of transfected parasite cell lines were done as indicated in the previous session.
Ethics statement. Animal infections were performed in strict accordance with the Brazil-
ian laws regarding animal use (LEI No 11.794, DE 8 DE OUTUBRO DE 2008). All protocols
were approved by the Committee on the Ethics of Animal Experiments of UFMG (protocol #
132/2014).
Supporting information
S1 Fig. Quality control metrics suggesting the removal of one sample. (A) Raw library sizes
were plotted to check for comparable sequencing depths for all samples, (B) boxplot of the
count distributions by gene. Hierarchical clustering analyses using Pearson correlation (C)
and Euclidean distances (E) along with Principal Component Analyses (D) and a standard
medium Pearson correlation between each sample (F) of the log2, cpm, quantile, and low-
count filtered data suggested the removal of sample ‘CLB.Tryp.1’.
(EPS)
S2 Fig. Growth curves of CL-14 epimastigotes transfected with a TS gene. Wild-type (WT)
CL-14 epimastigotes and cloned cell lines derived from CL-14 epimastigotes transfected with
the pROCK vector containing the TS gene TS95.30 (TS 14, TS 16, TS 18 and TS 22) as well as
CL-14 epimastigotes transfected with the empty pROCK vector were cultivated in LIT medium
for 9 days and the numbers of parasites were determined in a Neubauer chamber.
(TIFF)
S3 Fig. Infection of BALB/c mice with WT and transgenic CL-14. Groups of 5 animals were
inoculated with 5 x 103 tissue culture trypomastigotes from WT CL-14, from transgenic CL-14
cell lines TS 14 and TS or from CL Brener trypomastigotes and parasitemia was determined
during 30 days. The data shown are representative of three independent experiments.
(TIFF)
S4 Fig. Cell infection assays with CL-14 trypomastigotes at different temperatures. Vero
cells (5 x 104) were incubated with 5 x 105 CL-14 trypomastigotes at 37˚ or 34˚C and 5% CO2.
After 24 hours, cells were washed with phosphate buffered saline to eliminated extracellular
parasites and the numbers of trypomastigotes released in the supernatant were determined in
a Neubauer chamber. Infection assays were performed in triplicates.
(TIF)
S1 Table. Summary of samples collected, mapping statistics and experimental metadata.
This summarizes the experimental reference identifiers used in the experiment (columns
A-C), the experimental conditions (columns D-F), experimental batches (column G), numbers
of reads collected and mapped (columns H-J), and percentage mapped to the parasite and host
genomes (columns K-N).
(XLSX)
S2 Table. Differential expression for all contrasts and all genes using limma. The workbook
contains one worksheet for every contrast performed by limma, starting with the annotation
information provided by the TriTrypDb, followed by the limma statistics for every coding-
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sequence gene which passed low count filtering. A detailed legend is provided in the first work-
sheet.
(XLSX)
S3 Table. Lists of significant differentially expressed genes for all contrasts using limma.
This workbook contains the same information as in Table S2, but only for those genes which
are deemed ‘significantly differentially expressed’ using a |log2 fold change| > = 2.0 and
adjusted p-value < = 0.05. The worksheets are named according to the contrast performed,
and the direction of the fold change. The sheet ‘number_changed’ provides some summary
information regarding the numbers of observed differentially expressed genes according to
each tool employed.
(XLSX)
S4 Table. Expression values for individual genes. The metric of ‘expression’ was collected
from limma following the application of voom for each experimental condition. It is com-
prised of the normalized, batch-adjusted, expression value on the log2 scale. Errors were calcu-
lated by taking the logFC from the limma identity tables and dividing by the t-statistic for each
gene. The table contains annotations (columns A-E), followed by the metric of expression for
each condition (columns F-K), followed by the standard error (columns L-Q) for each condi-
tion.
(XLSX)
S5 Table. Analysis of expression trends in six T. cruzi multigene families. A two-sample
Kolmogorov–Smirnov test (K–S test) and a Welch’s two sample t-test for unequal variances
were run to test for significant differences in the distributions (K-S) and means (Welch’s) of
the logFC values for all members of each multigene family across development.
(XLSX)
S6 Table. Putative RNA-binding domain containing genes. Genes were identified using
homology searches to four protein domains known to be present in RNA binding proteins:
PUF (Pumilio), zinc finger, RNA recognition motif (RRM) and Alba domain. For most genes,
the two alleles (Esmeraldo-like and non-Esmeraldo-like) are shown.
(XLSX)
S7 Table. Raw counts for all samples. The workbook comprises 7 sheets. The first, ’legend’,
contains a legend and copy of the experimental design. The ’raw_reads’ sheet contains the gene
annotation data along with numbers of raw counts observed for each gene. The ’raw_graphs’ a
series of initial plots describing the raw data. The ’norm_data’ provides the counts after the nor-
malization applied as stated in the legend (log2, quantile, sva, filtered). The ’norm_graphs’ pro-
vides the same set of plots describing the normalized data. Finally, the ’median_data’ provides a
set of median values of the data after normalization by experimental conditions.
(XLSX)
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